What matters is making that choice based on accurate information rather than brand confusion or marketing claims that blur the line between supplements and medications
doi:10.1016/S0022-3565(24)38081-4
Understanding Semaglutide and GLP-1 Weight Loss Injections Semaglutide is a medication classified as a GLP-1 receptor agonist, which means it interacts with specific receptors in the body that play a role in regulating appetite and digestion as part of Semaglutide injection for weight loss
Journal of the American Pharmacists Association, 49 (5), S16-S29
Living with hemophilia means balancing many aspects of daily health, from managing bleeding risks to being mindful of possible medication interactions
In August 2024, Sesame introduced Success by Sesame, a direct-to-consumer weight loss program providing eligible patients access to compounded semaglutide and brand-name GLP-1 medications without retail markup